Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.
Dermatophytic Onychomycosis Therapeutics Market contains market size and forecasts of Dermatophytic Onychomycosis Therapeutics (DOT) in Global, including the following market information:
- Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Dermatophytic Onychomycosis Therapeutics (DOT) market was valued at 3492.6 million in 2021 and is projected to reach US$ 6756.8 million by 2028, at a CAGR of 9.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dermatophytic Onychomycosis Therapeutics (DOT) include Galderma, Bausch Health, Novartis, Pfizer and Janssen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dermatophytic Onychomycosis Therapeutics (DOT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatophytic Onychomycosis Therapeutics (DOT) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Segment Percentages, by Type, 2021 (%)
Global Dermatophytic Onychomycosis Therapeutics (DOT) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Dermatology And Podiatry Clinics
- Independent Pharmacies
- Mail Order Pharmacies
- Drug Stores
Global Dermatophytic Onychomycosis Therapeutics (DOT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Dermatophytic Onychomycosis Therapeutics (DOT) revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Dermatophytic Onychomycosis Therapeutics (DOT) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Galderma
- Bausch Health
- Novartis
- Pfizer
- Janssen
Industry Market Size
